16 November 2016 · The purpose of this document is to provide detailed guidance on the pharmaceutical quality assessment of unlicensed medicines. The principles are applicable both to unlicensed…
8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the HMR 2012
16 December 2016 · The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…
1 March 2022 · National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
5 December 2016 · This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.
21 January 2019 · This guidance will be of use to anyone purchasing, overlabelling or supplying imported
unlicensed medicines, and obtaining or providing translated leaflets.
10 October 2019 · A joint statement from the Neonatal and Paediatric Pharmacists' Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)